The continuous arterial infusion of 5-fluorouracil as a therapeutic adjunct in the treatment of advanced carcinoma of the bladder and prostate. A preliminary report.
D000368:Aged; D002277:Carcinoma / Q000188:drug therapy* / Q000532:radiotherapy; D003036:Cobalt Isotopes; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007269:Injections, Intra-Arterial; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000139:chemically induced; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011882:Radiotherapy, High-Energy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D003036:Cobalt Isotopes; D005472:Fluorouracil